Info

Hemispherx Biopharma, Inc. (Hemispherx) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based chronic disorders. The Company’s flagship products include Alferon N Injection, and the experimental therapeutics, Ampligen and Oragens. Alferon N Injection is a United States Food and Drug Administration (FDA)-approved product with an indication for refractory or recurring genital warts. Alferon LDO (low-dose oral) is the Company’s experimental liquid natural interferon for oral administration. Ampligen is an experimental drug that is undergoing clinical development for the treatment of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS), and human immunodeficiency virus (HIV). Ampligen and Oragens represent experimental ribonucleic acids (RNA) being developed for viral diseases and disorders of the immune system.(Source: 10-K)